BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6130021)

  • 1. Evidence for the presence of somatostatin 28 in plasma.
    Shoelson S; Polonsky K; Docherty H; Jaspan J; Rubenstein A
    Diabetes; 1982 May; 31(5 Pt 1):474-7. PubMed ID: 6130021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma somatostatin 28 increases in response to feeding in man.
    Polonsky KS; Shoelson SE; Docherty HM
    J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of somatostatin in peripheral and portal plasma in the duck: in-vivo metabolism of somatostatin-28 and -14.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    J Endocrinol; 1984 Mar; 100(3):329-35. PubMed ID: 6142074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-like immunoreactivity (SLI) in pancreatic and intestinal tissues of the duck. A possible origin for the portal circulating SLI.
    Di Scala-Guenot D; Strosser MT; Mialhe P
    Horm Metab Res; 1985 Nov; 17(11):566-71. PubMed ID: 2867025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin-like immunoreactivity in mammalian thyroid glands: contents and partial characterization.
    Oyama H; Kameda Y; Endoh M; Nagase Y; Matsuki M; Kakita K; Tenku A; Nishida S; Horino M
    Endocrinology; 1984 Mar; 114(3):1028-32. PubMed ID: 6141931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for multiple molecular weight forms of somatostatin-like material in Escherichia coli.
    LeRoith D; Pickens W; Crosby LK; Berelowitz M; Holtgrefe M; Shiloach J
    Biochim Biophys Acta; 1985 Mar; 838(3):335-42. PubMed ID: 2857577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersomatostatinemia in chronic renal failure.
    Wasada T; Inoue K; Fujimi S; Sako Y; Hisatomi A; Ibayashi H
    Endocrinol Jpn; 1987 Apr; 34(2):251-6. PubMed ID: 2887424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.
    Conlon JM; Srikant CB; Ipp E; Schusdziarra V; Vale W; Unger RH
    J Clin Invest; 1978 Dec; 62(6):1187-93. PubMed ID: 748373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for somatostatin precursors in human stomach, placenta, and amniotic fluid.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):372-6. PubMed ID: 6114109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating forms of somatostatinlike immunoreactivity in human plasma.
    Shoelson SE; Polonsky KS; Nakabayashi T; Jaspan JB; Tager HS
    Am J Physiol; 1986 Apr; 250(4 Pt 1):E428-34. PubMed ID: 3963183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of substance P and neurotensin on somatostatin levels in rat portal plasma.
    Saito H; Saito S
    Endocrinology; 1980 Nov; 107(5):1600-5. PubMed ID: 6159202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of somatostatin-like immunoreactivity from the lower gut.
    Rouiller D; Schusdziarra V; Conlon JM; Harris V; Unger RH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):700-3. PubMed ID: 467926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
    Patel YC; Ganda OP; Benoit R
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic extraction of somatostatin in conscious dogs.
    Chap Z; Ishida T; Jones RH; Pena JR; Vinik A; Field JB
    Am J Physiol; 1988 Feb; 254(2 Pt 1):E214-21. PubMed ID: 2894771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that somatostatin (SRIF14) is the primary coligand in pancreas required for specific binding of [3H]estradiol in pancreatic tissue: demonstration that [3H]estradiol and [125I]SRIF14 form complexes of varying size with a specific binding protein.
    Grossman A; Richardson SB; Moloshok T; Frangione B
    J Steroid Biochem; 1984 Sep; 21(3):279-86. PubMed ID: 6149333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high molecular weight form of somatostatin-28 (1-12)-like immunoreactive substance without somatostatin-14 immunoreactivity in the rat pancreas. Evidence that somatostatin-14 synthesis can occur independently of somatostatin-28.
    Patel YC
    J Clin Invest; 1983 Dec; 72(6):2137-43. PubMed ID: 6139388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive somatostatin in rat hypophysial portal blood.
    Gillioz P; Giraud P; Conte-Devolx B; Jaquet P; Codaccioni JL; Oliver C
    Endocrinology; 1979 May; 104(5):1407-10. PubMed ID: 436785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of plasma somatostatin-like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subjects and patients with impaired glucose tolerance.
    Itoh M; Hirooka Y; Nihei N
    Acta Endocrinol (Copenh); 1983 Dec; 104(4):468-74. PubMed ID: 6140806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.